Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION (CVS)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

CVS Health : Research Institute Study Shows 11.4 Percentage Point Improvement in Medication Adherence Among Patients in Specialty Connect Pilot

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/10/2016 | 04:13am CEST

WOONSOCKET, R.I., Jan. 29, 2016/PRNewswire/ --New research published by the CVS Health (NYSE: CVS) Research Institute showed a significant improvement in adherence to specialty medications for patients enrolled in a pilot study evaluating Specialty Connect, CVS Health's innovative specialty prescription services program. New patients enrolled in the pilot were 17.5 percent more likely to pick up their first refill and existing specialty patients had an 11.4 percentage point improvement in adherence, as compared to a control group. The study was published in the most recent issue of the Journal of the American Pharmacists Association.

'The specialty market is growing rapidly and new high-cost specialty drugs, that were once limited to small patient populations, are now increasingly being indicated to treat many more patients,' said William Shrank, M.D., chief scientific officer and senior vice president, CVS Health. 'As new specialty medications are introduced, adherence to therapy will be particularly important to optimize the benefit of these very expensive medications. Specialty Connect, combined with evidence-based benefit design and utilization management strategies, can increase the likelihood that the most appropriate patients receive specialty medications and that, once received, they take them as prescribed.'

CVS Health piloted the Specialty Connect program in 115 CVS Pharmacy stores before launching the program nationwide. Patients enrolled in the pilot could choose to have medications delivered to their home or doctor's office or opt to pick up their specialty medications at their local CVS Pharmacy, while receiving specialized clinical support from CVS Specialty, the specialty pharmacy of CVS Health. Since the program's launch, more than 100,000 patients have been served, with more than half choosing to pick up their specialty prescriptions at retail.

Specialty medicines treat complex conditions such as rheumatoid arthritis, multiple sclerosis and hepatitis C. Many of these medications require special handling, storage and administration. In addition, many specialty drugs are only available at select specialty pharmacies to help ensure compliance with required safety and compliance protocols. As a result, patients often have difficulty with the logistics of filling a new prescription for a specialty medication, with as many as one quarter of traditional retail pharmacies unable to fill a specialty prescription without barriers and/or delays. CVS Specialty is the only specialty pharmacy that offers patients a choice of where to get their medicines, either at any CVS Pharmacy location or through mail delivery, which simplifies getting started on a specialty therapy. In addition, the Specialty Care Team provides round-the-clock support and patient care, including symptom management, claims processing and help managing comorbid conditions.

'CVS Specialty is the only specialty pharmacy that integrates rare disease management and coordinated care programs to make it easier for patients to start and stay on complex treatments,' added Alan Lotvin, M.D., president, CVS Specialty and executive vice president, CVS Health. 'Since we launched Specialty Connect across all CVS Pharmacy locations, we have seen high rates of adherence, and our specialty patients have reported extremely high satisfaction with their service.'

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives. CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

About CVS Health
CVS Health is a pharmacy innovation company helping people on their path to better health. Through its more than 9,500 retail pharmacies, more than 1,100 walk-in medical clinics, a leading pharmacy benefits manager with more than 70 million plan members, a dedicated senior pharmacy care business serving more than one million patients per year, and expanding specialty pharmacy services, the Company enables people, businesses and communities to manage health in more affordable, effective ways. This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs. Find more information about how CVS Health is shaping the future of health atwww.cvshealth.com.

Logo- http://photos.prnewswire.com/prnh/20140905/143585

SOURCE CVS Health

CVS Health Corporation issued this content on 29 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 February 2016 03:12:28 UTC

Original Document: http://www.cvshealth.com/content/cvs-health-research-institute-study-shows-114-percentage-point-improvement-medication

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
05/25Pfizer to pay $23.85 million to settle U.S. co-payment kickback probe
RE
05/18CVS HEALTH : AG Curtis Hill Lauds CVS Officials for Drug-Disposal Plans
AQ
05/17CVS HEALTH : AG Curtis Hill to Join CVS Officials to Discuss Drug Disposal
AQ
05/14U.S. to consider expanding Medicare drug price negotiation
RE
05/14CVS HEALTH : Thinking about buying stock in Apple, CVS Health Corp, Facebook, Sy..
PR
05/12CVS HEALTH : installs medication disposal units across the state
AQ
05/12Trump assails high drug prices, avoids direct hit on industry
RE
05/11Trump's Plan to Cut Drug Prices Leaves Industry Relieved
DJ
05/11CVS HEALTH : Foundation gives $20K to Free Clinic of Meridian
AQ
05/11CVS HEALTH : Statement on Trump Administration Initiative to Reduce Drug Costs
PR
More news
News from SeekingAlpha
05/25Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2018 Updat.. 
05/24Thomson Reuters Retail And Restaurant Aggregate Estimates And Revisions Q1 20.. 
05/24TOP WALL STREET HEALTHCARE GAINERS F : Allergan, CVS Health, Patterson, Sanofi, .. 
05/22GOLDMAN SACHS : Hedge funds betting against Nvidia, Intel 
05/2110 Dividend Growth Stocks For May 2018 
Financials ($)
Sales 2018 189 B
EBIT 2018 9 961 M
Net income 2018 5 331 M
Debt 2018 19 170 M
Yield 2018 3,03%
P/E ratio 2018 12,92
P/E ratio 2019 10,05
EV / Sales 2018 0,46x
EV / Sales 2019 0,43x
Capitalization 67 129 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 86,4 $
Spread / Average Target 31%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH CORPORATION-10.18%67 129
WALGREENS BOOTS ALLIANCE-12.68%63 001
EXPRESS SCRIPTS HOLDING CO3.27%43 297
MCKESSON CORPORATION-6.50%30 086
AMERISOURCEBERGEN-6.89%18 791
CARDINAL HEALTH-14.41%16 503